HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Douche complaints, demographics requested from industry in FDA letter.

This article was originally published in The Rose Sheet

Executive Summary

VAGINAL DOUCHE USE PATTERNS, COMPLAINT INFO REQUESTED BY FDA in a Feb. 19 letter to douche manufacturers and associated trade groups from the agency's Division of OTC Drug Products Director Debra Bowen, MD. The letter was issued to solicit information in preparation for the April 15 joint meeting of FDA's Nonprescription Drugs, Anti-infective Drugs and Reproductive Drugs Advisory Committees and members from the Center for Devices & Radiological Health, to review vaginal douche safety ("The Rose Sheet" Feb. 24, p. 6).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel